HomePage | Biosensors International Ltd

Spotlight BioMimics 3D™
Biosensors Enters Into Distribution Agreement with Veryan for BioMimics 3D Stent
Biosensors International Group has announced (28 January 2015) a distribution agreement with Veryan Medical Ltd. for BioMimics 3D™, a nitinol stent with unique three-dimensional helical geometry designed for use in the superficial femoral artery. The agreement covers certain international markets, but excludes the USA and Japan.
BioMatrix NEOFLEX™
BioMatrix NeoFlex™ is the latest addition to the BioMatrix family of drug-eluting stents (DES).™
It features an enhanced catheter delivery system with a lower entry profile than its predecessor, so improving pushability, trackability and crossability. BioMatrix NeoFlex retains the same unique combination of abluminal biodegradable polymer coating, Biolimus A9™ and flexible platform which have made the BioMatrix family of DES so popular.

Spotlight BioFreedom™
Spotlight BioFreedom™ DAPT
Duration: How Low Can You Go?
An update on BioFreedom clinical trials around the world, featuring interviews with the Principal Investigators from LEADERS Free; LEADERS Free Japan; The US IDE trial; and EGO BioFreedom.
Watch the video
1 month DAPT: BioFreedom™ –
a patient-centric approach to coronary stenting.
This TCT 2014 symposium discussed potential for improving patient experienceof stenting by lowering the duration of DAPT.
FY15 Q4 and Full Year Financial Results Webcast Archive Wednesday, 27 May 2015, 6pm Singapore time